JPWO2023125102A5 - - Google Patents

Info

Publication number
JPWO2023125102A5
JPWO2023125102A5 JP2024539899A JP2024539899A JPWO2023125102A5 JP WO2023125102 A5 JPWO2023125102 A5 JP WO2023125102A5 JP 2024539899 A JP2024539899 A JP 2024539899A JP 2024539899 A JP2024539899 A JP 2024539899A JP WO2023125102 A5 JPWO2023125102 A5 JP WO2023125102A5
Authority
JP
Japan
Prior art keywords
compound
reaction
solvent
solution
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024539899A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024546195A5 (https=
JP2024546195A (ja
Publication date
Priority claimed from CN202111658903.5A external-priority patent/CN114213424B/zh
Application filed filed Critical
Publication of JP2024546195A publication Critical patent/JP2024546195A/ja
Publication of JPWO2023125102A5 publication Critical patent/JPWO2023125102A5/ja
Publication of JP2024546195A5 publication Critical patent/JP2024546195A5/ja
Pending legal-status Critical Current

Links

JP2024539899A 2021-12-30 2022-12-19 １ｈ－フロ［３，２－ｂ］イミダゾ［４，５－ｄ］ピリジン化合物の合成方法 Pending JP2024546195A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202111658903.5A CN114213424B (zh) 2021-12-30 2021-12-30 一种呋喃[3，2-b]并吡啶衍生物的合成方法
CN202111658903.5 2021-12-30
PCT/CN2022/139966 WO2023125102A1 (zh) 2021-12-30 2022-12-19 1H-呋喃并[3,2-b]咪唑并[4,5-d]吡啶化合物的合成方法

Publications (3)

Publication Number Publication Date
JP2024546195A JP2024546195A (ja) 2024-12-17
JPWO2023125102A5 true JPWO2023125102A5 (https=) 2025-12-26
JP2024546195A5 JP2024546195A5 (https=) 2025-12-26

Family

ID=80707144

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024539899A Pending JP2024546195A (ja) 2021-12-30 2022-12-19 １ｈ－フロ［３，２－ｂ］イミダゾ［４，５－ｄ］ピリジン化合物の合成方法

Country Status (10)

Country Link
US (1) US20250171458A1 (https=)
EP (1) EP4509509A1 (https=)
JP (1) JP2024546195A (https=)
KR (1) KR20240129021A (https=)
CN (2) CN114213424B (https=)
AU (1) AU2022426316A1 (https=)
CA (1) CA3244846A1 (https=)
IL (1) IL313966A (https=)
MX (1) MX2024008276A (https=)
WO (1) WO2023125102A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102399848B1 (ko) 2016-10-03 2022-05-19 하이라이트ll 파머슈티컬 (하이난) 컴퍼니, 리미티드 신규한 jak1 선택적 억제제 및 그 용도
CN114213424B (zh) * 2021-12-30 2023-05-26 杭州高光制药有限公司 一种呋喃[3，2-b]并吡啶衍生物的合成方法
WO2025224600A1 (en) * 2024-04-21 2025-10-30 Biohaven Therapeutics Ltd. Treatment of alpha-synucleinopathies and neuroprotection

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007039146A1 (en) * 2005-09-23 2007-04-12 Smithkline Beecham Corporation 4-carboxy pyrazole derivatives as anti-viral agents
WO2011138657A1 (en) * 2010-05-04 2011-11-10 Glenmark Pharmaceuticals S.A. Aryl substituted olefinic compounds as pde10a inhibitors
JP6057907B2 (ja) * 2011-10-04 2017-01-11 株式会社ヤクルト本社 チアゾリジン誘導体又はその塩を有効成分とする医薬品
CN103450125B (zh) * 2013-07-18 2016-01-13 嘉兴中科化学有限公司 一种5-取代苯丙呋喃-2-羧酸及其衍生物的合成方法
EP2940022B1 (en) * 2014-04-30 2020-09-02 Masarykova Univerzita Furopyridines as inhibitors of protein kinases
CN105418620B (zh) * 2014-09-23 2018-05-04 天津药明康德新药开发有限公司 一种4-(叔丁氧羰基)八氢呋喃并[3,2-b]吡啶-6-羧酸的合成方法
WO2016100349A2 (en) * 2014-12-16 2016-06-23 Rugen Holdings (Cayman) Limited Bicyclic azaheterocyclic compounds as nr2b nmda receptor antagonists
WO2016196244A1 (en) * 2015-05-29 2016-12-08 Incyte Corporation Pyridineamine compounds useful as pim kinase inhibitors
CN106432232A (zh) * 2016-09-18 2017-02-22 苏州汉德创宏生化科技有限公司 1‑哌啶‑4‑基‑1,3‑二氢‑咪唑[4,5‑b]吡啶‑2‑酮的合成方法
KR102399848B1 (ko) 2016-10-03 2022-05-19 하이라이트ll 파머슈티컬 (하이난) 컴퍼니, 리미티드 신규한 jak1 선택적 억제제 및 그 용도
CN107216334A (zh) * 2017-06-29 2017-09-29 上海吉尔多肽有限公司 一种6‑氯呋喃[3,2‑b]吡啶的合成方法
CN118619944A (zh) * 2019-06-06 2024-09-10 北京泰德制药股份有限公司 作为atr激酶抑制剂的2,4,6-三取代的嘧啶化合物
KR102785014B1 (ko) 2019-06-06 2025-03-20 항저우 하이라이트엘엘 파마슈티컬 씨오., 엘티디. 푸로이미다조피리딘 화합물의 합성 방법, 푸로이미다조피리딘 화합물의 결정 형태, 및 그의 염의 결정 형태
IL318796A (en) 2019-06-06 2025-04-01 Hangzhou Highlightll Pharmaceutical Co Ltd Method for preparing a furoimidazopyridine compound, polymorph and salt polymorph
CN114213424B (zh) * 2021-12-30 2023-05-26 杭州高光制药有限公司 一种呋喃[3，2-b]并吡啶衍生物的合成方法

Similar Documents

Publication Publication Date Title
TWI419867B (zh) 用於製備整合酶抑制劑之方法及中間體
CN107176955B (zh) 一种巴瑞替尼的制备方法
CN104159898A (zh) 用于制备取代的5-氟-1h-吡唑并吡啶类化合物的方法
CN110950765B (zh) 一种硫酸特布他林的制备方法
WO2003014087A1 (fr) Procede de preparation de 5-methyl-1-phenyl-2(1h)-pyridinone
CN112300073B (zh) 一种异喹啉衍生物的制备方法
CN117164568B (zh) 一种Resmetirom中间体及其制备方法以及中间体III的制备方法
CN103373989A (zh) 盐酸帕唑帕尼的中间体的制备方法
CN114621109B (zh) 一种阿帕他胺的合成方法及其中间体
JPWO2023125102A5 (https=)
CN112409258B (zh) 一种罗沙司他的制备方法
CN109776407B (zh) 一种2-甲基-4-羟甲基喹啉及其衍生物的制备方法
CN103980120A (zh) 一种混旋丹参素异丙酯的合成方法
CN113105357A (zh) 一种新型对芳基偶氮苯酚衍生物的合成方法及其应用
CN103044383B (zh) 一种制备天然产物Penicillide消旋体的方法
CN103373963B (zh) 盐酸帕唑帕尼的中间体及其制备方法
CN107955029B (zh) 一种雷西纳德的制备方法
CN118666695A (zh) 一种重酒石酸间羟胺的合成方法
CN114751836B (zh) 3-(4-甲基-1h-咪唑-1-基)-5-(三氟甲基)苯胺合成方法及其中间体
CN110143910B (zh) 一种多取代吡咯烷酮衍生物的制备方法
CN118459425B (zh) 一种吡咯烷-1-胺-二盐酸盐的制备方法
CN119613373B (zh) 一种苯并碘氧杂戊环试剂的制备方法
CN112745205B (zh) 辛波莫德中间体的制备方法
CN105601604B (zh) 血竭素及其盐、中间体的制备方法以及这些中间体化合物
CN112442005B (zh) 一种n-磺酰基亚胺香豆素衍生物及其制备方法